Breakthrough drug trial aims to save kidneys in type 1 diabetes
Disease control
Recruiting now
This study is testing whether a pill called sotagliflozin can slow down kidney damage in 150 people who have both type 1 diabetes and moderate to severe kidney disease. Participants will take either the real pill or a placebo (inactive pill) daily for three years, while following…
Phase: PHASE3 • Sponsor: Alessandro Doria • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC